Top Pharmaceuticals companies in France by Return on Assets (ROA)
France
# |
Name |
Return on Assets (ROA) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
28.34%
|
Dec. 31, 2023 | USD 4.50 | -0.52% |
|
France |
|
| 2 |
11.94%
|
Dec. 31, 2023 | USD 38.29 | -1.09% |
|
France |
|
| 3 |
10.19%
|
Dec. 31, 2023 | USD 123.44 | -0.03% |
|
France |
|
| 4 |
8.03%
|
Dec. 31, 2023 | USD 72.01 | -1.14% |
|
France |
|
| 5 |
6.80%
|
Dec. 31, 2023 | USD 121.47 | 0.49% |
|
France |
|
| 6 |
6.07%
|
Dec. 31, 2023 | USD 26.03 | -0.48% |
|
France |
|
| 7 |
4.92%
|
Dec. 31, 2023 | USD 3.53 | 3.05% |
|
France |
|
| 8 |
4.27%
|
Dec. 31, 2023 | USD 107.67 | 1.44% |
|
France |
|
| 9 |
4.00%
|
Dec. 31, 2023 | USD 234.21 | -0.06% |
|
France |
|
| 10 |
2.77%
|
Dec. 31, 2023 | USD 80.53 | 0.17% |
|
France |
|
| 11 |
2.33%
|
Dec. 31, 2023 | USD 28.11 | -1.74% |
|
France |
|
| 12 |
1.76%
|
Dec. 31, 2023 | USD 8.00 | -1.82% |
|
France |
|
| 13 |
1.53%
|
Dec. 31, 2023 | USD 26.81 | 1.48% |
|
France |
|
| 14 |
0.55%
|
June 30, 2024 | USD 3.43 | 2.19% |
|
France |
|
| 15 |
-0.14%
|
June 30, 2024 | USD 23.59 | 5.53% |
|
France |
|
| 16 |
-0.78%
|
June 30, 2024 | USD 11.22 | 0.65% |
|
France |
|
| 17 |
-0.80%
|
Dec. 31, 2023 | USD 12.00 | -0.29% |
|
France |
|
| 18 |
-4.11%
|
Dec. 31, 2023 | USD 1.82 | 1.45% |
|
France |
|
| 19 |
-10.87%
|
Dec. 31, 2023 | USD 1.61 | 1.02% |
|
France |
|
| 20 |
-11.77%
|
Dec. 31, 2023 | USD 3.21 | 1.35% |
|
France |
|
| 21 |
-15.28%
|
Dec. 31, 2023 | USD 1.31 | 15.27% |
|
France |
|
| 22 |
-16.62%
|
Dec. 31, 2023 | USD 3.82 | 3.95% |
|
France |
|
| 23 |
-19.32%
|
Dec. 31, 2023 | USD 3.91 | -21.89% |
|
France |
|
| 24 |
-21.14%
|
Dec. 31, 2023 | USD 0.68 | 4.81% |
|
France |
|
| 25 |
-22.05%
|
Dec. 31, 2023 | USD 2.56 | 3.94% |
|
France |
|
| 26 |
-22.12%
|
Dec. 31, 2023 | USD 1.42 | -2.42% |
|
France |
|
| 27 |
-23.13%
|
Dec. 31, 2023 | USD 2.30 | 0.88% |
|
France |
|
| 28 |
-23.72%
|
Dec. 31, 2023 | USD 1.28 | -1.09% |
|
France |
|
| 29 |
-27.64%
|
Dec. 31, 2023 | USD 1.43 | 2.69% |
|
France |
|
| 30 |
-28.03%
|
Dec. 31, 2023 | USD 6.91 | 1.86% |
|
France |
|
| 31 |
-30.16%
|
Dec. 31, 2023 | USD 2.14 | -0.29% |
|
France |
|
| 32 |
-30.23%
|
Dec. 31, 2023 | USD 1.58 | 0.37% |
|
France |
|
| 33 |
-39.41%
|
Dec. 31, 2023 | USD 1.68 | -2.10% |
|
France |
|
| 34 |
-39.74%
|
Dec. 31, 2023 | USD 4.26 | 0.95% |
|
France |
|
| 35 |
-42.28%
|
Dec. 31, 2023 | USD 3.56 | 1.19% |
|
France |
|
| 36 |
-45.17%
|
Dec. 31, 2023 | USD 6.10 | -0.29% |
|
France |
|
| 37 |
-45.78%
|
Dec. 31, 2023 | USD 1.87 | -0.29% |
|
France |
|
| 38 |
-45.93%
|
Dec. 31, 2023 | USD 8.25 | -0.54% |
|
France |
|
| 39 |
-47.90%
|
Dec. 31, 2023 | USD 4.03 | -0.29% |
|
France |
|
| 40 |
-56.67%
|
Dec. 31, 2023 | USD 2.13 | 2.21% |
|
France |
|
| 41 |
-63.95%
|
Dec. 31, 2023 | USD 3.69 | 4.73% |
|
France |
|
| 42 |
-67.77%
|
March 31, 2024 | USD 16.15 | -3.27% |
|
France |
|
| 43 |
-84.80%
|
Dec. 31, 2023 | USD 6.11 | -1.79% |
|
France |
|
| 44 |
-94.33%
|
Dec. 31, 2023 | USD 1.71 | -4.34% |
|
France |
|
| 45 |
-158.75%
|
Dec. 31, 2023 | USD 2.41 | 7.10% |
|
France |
Frequently Asked Questions
-
Which Pharmaceuticals company in France has the highest Return on Assets (ROA) ?
The Pharmaceuticals company in France with the highest Return on Assets (ROA) is Euromedis Groupe (Paris Stock Exchange: ALEMG.PA) at 28.34%.
-
Which Pharmaceuticals company in France has the lowest Return on Assets (ROA) ?
The Pharmaceuticals company in France with the lowest Return on Assets (ROA) is Inventiva S.A. (Paris Stock Exchange: IVA.PA) at -158.75%.
-
What are the top 10 Pharmaceuticals companies in France by Return on Assets (ROA) ?
The top 10 Pharmaceuticals companies in France by Return on Assets (ROA) are Euromedis Groupe, Equasens SA, Ipsen S.A., Vetoquinol SA, bioMérieux S.A., Boiron SA, genOway SA, Sanofi, Sartorius Stedim Biotech S.A. and Arkema S.A..
-
What are the bottom 10 Pharmaceuticals companies in France by Return on Assets (ROA) ?
The bottom 10 Pharmaceuticals companies in France by Return on Assets (ROA) are Inventiva S.A., NFL Biosciences SA, Adocia SA, MedinCell S.A., Median Technologies SA, Advicenne S.A., Predilife S.A., MaaT Pharma SA, PHAXIAM Therapeutics S.A. and ABIVAX SA.
